 Substance Withdrawal Syndrome
"Substance Withdrawal Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Descriptor ID |
D013375
|
| MeSH Number(s) |
C25.835 F03.900.825
|
| Concept/Terms |
Substance Withdrawal Syndrome- Substance Withdrawal Syndrome
- Substance Withdrawal Syndromes
- Syndrome, Substance Withdrawal
- Syndromes, Substance Withdrawal
- Withdrawal Syndrome, Substance
- Withdrawal Syndromes, Substance
Withdrawal Symptoms- Withdrawal Symptoms
- Symptom, Withdrawal
- Symptoms, Withdrawal
- Withdrawal Symptom
Drug Withdrawal Symptoms- Drug Withdrawal Symptoms
- Drug Withdrawal Symptom
- Symptom, Drug Withdrawal
- Symptoms, Drug Withdrawal
- Withdrawal Symptom, Drug
- Withdrawal Symptoms, Drug
|
Below are MeSH descriptors whose meaning is more general than "Substance Withdrawal Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Substance Withdrawal Syndrome".
This graph shows the total number of publications written about "Substance Withdrawal Syndrome" by people in UAMS Profiles by year, and whether "Substance Withdrawal Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 2 | 0 | 2 | | 2019 | 1 | 0 | 1 | | 2018 | 1 | 3 | 4 | | 2017 | 4 | 2 | 6 | | 2016 | 5 | 1 | 6 | | 2015 | 2 | 2 | 4 | | 2014 | 2 | 0 | 2 | | 2013 | 1 | 3 | 4 | | 2012 | 5 | 1 | 6 | | 2011 | 5 | 3 | 8 | | 2010 | 2 | 1 | 3 | | 2009 | 1 | 3 | 4 | | 2008 | 1 | 2 | 3 | | 2007 | 4 | 0 | 4 | | 2006 | 5 | 1 | 6 | | 2005 | 5 | 2 | 7 | | 2004 | 4 | 1 | 5 | | 2003 | 2 | 0 | 2 | | 2002 | 2 | 2 | 4 | | 2001 | 3 | 0 | 3 | | 2000 | 0 | 1 | 1 | | 1999 | 2 | 2 | 4 | | 1998 | 1 | 1 | 2 | | 1997 | 5 | 0 | 5 | | 1996 | 4 | 1 | 5 | | 1995 | 3 | 4 | 7 | | 1994 | 0 | 2 | 2 | | 1993 | 1 | 1 | 2 | | 1992 | 1 | 2 | 3 | | 1991 | 3 | 1 | 4 | | 1990 | 1 | 3 | 4 | | 1989 | 6 | 2 | 8 | | 1988 | 4 | 1 | 5 | | 1987 | 0 | 1 | 1 | | 1986 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Substance Withdrawal Syndrome" by people in Profiles over the past ten years.
-
Evans L, Lewis ZB, Seupaul RA. Can We Predict Severe Alcohol Withdrawal Syndrome? Ann Emerg Med. 2020 09; 76(3):328-329.
-
Gupta HV. Teaching Video NeuroImages: Tardive diaphragmatic tremor. Neurology. 2020 02 11; 94(6):e656.
-
Griffin BA, Caperton CO, Russell LN, Cabanlong CV, Wilson CD, Urquhart KR, Martins BS, Zita MD, Patton AL, Alund AW, Owens SM, Fantegrossi WE, Moran JH, Brents LK. In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome. J Pharmacol Exp Ther. 2019 07; 370(1):9-17.
-
Coker JL, Catlin D, Ray-Griffith S, Knight B, Stowe ZN. Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence. Drug Alcohol Depend. 2018 11 01; 192:146-149.
-
Yadlapalli JSK, Bommagani SB, Mahelona RD, Wan A, Gannon BM, Penthala NR, Dobretsov M, Crooks PA, Fantegrossi WE. Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependence. Pharmacol Res Perspect. 2018 07; 6(4):e00403.
-
Schlienz NJ, Lee DC, Stitzer ML, Vandrey R. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Drug Alcohol Depend. 2018 06 01; 187:254-260.
-
Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend. 2018 03 01; 184:57-63.
-
Sweitzer MM, Kollins SH, Kozink RV, Hallyburton M, English J, Addicott MA, Oliver JA, McClernon FJ. ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge. Neuropsychopharmacology. 2018 03; 43(4):851-858.
-
Berquist MD, Hyatt WS, Bauer-Erickson J, Gannon BM, Norwood AP, Fantegrossi WE. Phencyclidine-like in vivo effects of methoxetamine in mice and rats. Neuropharmacology. 2018 05 15; 134(Pt A):158-166.
-
Patel S, Garcia X, Mohammad ME, Yu XX, Vlastaris K, O'Donnell K, Sutton K, Fernandez HH. Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson disease treatment center. J Neurol Sci. 2017 Aug 15; 379:308-311.
-
Oliver JA, Evans DE, Addicott MA, Potts GF, Brandon TH, Drobes DJ. Nicotine Withdrawal Induces Neural Deficits in Reward Processing. Nicotine Tob Res. 2017 Jun 01; 19(6):686-693.
-
Hughes JR, Budney AJ, Muellers SR, Lee DC, Callas PW, Sigmon SC, Fingar JR, Priest J. Does Tobacco Abstinence Decrease Reward Sensitivity? A Human Laboratory Test. Nicotine Tob Res. 2017 Jun 01; 19(6):677-685.
-
Rabin RA, Kozak K, Zakzanis KK, Remington G, Stefan C, Budney AJ, George TP. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophr Res. 2018 04; 194:47-54.
-
Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Zvorsky I, Redner R, Vandrey R, Pacek LR. Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. Psychopharmacology (Berl). 2017 Jan; 234(1):89-98.
-
Puening SE, Wilson MP, Nordstrom K. Psychiatric Emergencies for Clinicians: Emergency Department Management of Benzodiazepine Withdrawal. J Emerg Med. 2017 01; 52(1):66-69.
-
Simpson SA, Wilson MP, Nordstrom K. Psychiatric Emergencies for Clinicians: Emergency Department Management of Alcohol Withdrawal. J Emerg Med. 2016 Sep; 51(3):269-73.
-
Sweitzer MM, Geier CF, Addicott MA, Denlinger R, Raiff BR, Dallery J, McClernon FJ, Donny EC. Smoking Abstinence-Induced Changes in Resting State Functional Connectivity with Ventral Striatum Predict Lapse During a Quit Attempt. Neuropsychopharmacology. 2016 09; 41(10):2521-9.
-
Dutta N, Helton SG, Schwandt M, Zhu X, Momenan R, Lohoff FW. Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal Severity. Alcohol Clin Exp Res. 2016 Mar; 40(3):474-81.
-
Hughes JR, Naud S, Budney AJ, Fingar JR, Callas PW. Attempts to stop or reduce daily cannabis use: An intensive natural history study. Psychol Addict Behav. 2016 05; 30(3):389-97.
-
Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, McClernon FJ, Montoya ID, Murphy SE, Robinson JD, Stitzer ML, Strasser AA, Tindle H, Hatsukami DK. Randomized Trial of Reduced-Nicotine Standards for Cigarettes. N Engl J Med. 2015 Oct; 373(14):1340-9.
-
McClernon FJ, Conklin CA, Kozink RV, Adcock RA, Sweitzer MM, Addicott MA, Chou YH, Chen NK, Hallyburton MB, DeVito AM. Hippocampal and Insular Response to Smoking-Related Environments: Neuroimaging Evidence for Drug-Context Effects in Nicotine Dependence. Neuropsychopharmacology. 2016 Feb; 41(3):877-85.
-
Tai S, Nikas SP, Shukla VG, Vemuri K, Makriyannis A, Järbe TU. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist. Psychopharmacology (Berl). 2015 Aug; 232(15):2751-61.
-
McClernon FJ, Addicott MA, Sweitzer MM. Smoking abstinence and neurocognition: implications for cessation and relapse. Curr Top Behav Neurosci. 2015; 23:193-227.
-
Timko C, Below M, Schultz NR, Brief D, Cucciare MA. Patient and program factors that bridge the detoxification-treatment gap: a structured evidence review. J Subst Abuse Treat. 2015 May; 52:31-9.
-
De Biasi M, McLaughlin I, Perez EE, Crooks PA, Dwoskin LP, Bardo MT, Pentel PR, Hatsukami D. Scientific overview: 2013 BBC plenary symposium on tobacco addiction. Drug Alcohol Depend. 2014 Aug 01; 141:107-17.
-
Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013 Aug; 170(8):834-51.
-
Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, Oliveto AH. Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure. Exp Clin Psychopharmacol. 2013 Aug; 21(4):294-302.
-
Oliveto A, Mancino M, Sanders N, Cargile C, Benjamin Guise J, Bickel W, Brooks Gentry W. Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. Eur J Pharmacol. 2013 Sep 05; 715(1-3):424-35.
-
Fu JJ, Zaller ND, Yokell MA, Bazazi AR, Rich JD. Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States. J Subst Abuse Treat. 2013 May-Jun; 44(5):502-5.
-
Kollins SH, English JS, Roley ME, O'Brien B, Blair J, Lane SD, McClernon FJ. Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder. Psychopharmacology (Berl). 2013 May; 227(1):19-30.
-
Wiggins WF, Graef JD, Huitt TW, Godwin DW. Ethosuximide reduces ethanol withdrawal-mediated disruptions in sleep-related EEG patterns. Alcohol Clin Exp Res. 2013 Mar; 37(3):372-82.
-
Allsop DJ, Copeland J, Norberg MM, Fu S, Molnar A, Lewis J, Budney AJ. Quantifying the clinical significance of cannabis withdrawal. PLoS One. 2012; 7(9):e44864.
-
Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend. 2013 Feb 01; 128(1-2):64-70.
-
Agrawal A, Budney AJ, Lynskey MT. The co-occurring use and misuse of cannabis and tobacco: a review. Addiction. 2012 Jul; 107(7):1221-33.
-
Yi R, Landes RD. Temporal and probability discounting by cigarette smokers following acute smoking abstinence. Nicotine Tob Res. 2012 May; 14(5):547-58.
-
McClure EA, Stitzer ML, Vandrey R. Characterizing smoking topography of cannabis in heavy users. Psychopharmacology (Berl). 2012 Mar; 220(2):309-18.
-
Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J Addict Med. 2011 Sep; 5(3):175-80.
-
Addicott MA, Baranger DA, Kozink RV, Smoski MJ, Dichter GS, McClernon FJ. Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation: a preliminary study. Psychopharmacology (Berl). 2012 Jan; 219(2):563-73.
-
Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011 Dec 01; 119(1-2):123-9.
-
Schacht JP, Randall PK, Waid LR, Baros AM, Latham PK, Wright TM, Myrick H, Anton RF. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res. 2011 Nov; 35(11):2030-8.
-
Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011 Jul; 168(7):709-17.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|